COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma.
暂无分享，去创建一个
P. Ascierto | I. Krajsová | A. Arance | Ralf Gutzmer | Claus Garbe | Caroline Robert | D. Schadendorf | Helen J. Gogas | P. Queirolo | Mario Mandalá | C.A. Guenzel | Reinhard Dummer | K.T. Flaherty | J. W. D. de Groot | G. Liszkay | C. Loquai | N. Yamazaki | A. Polli | M. Thakur | A. di Pietro